We recently published a body of experiments demonstrating that antigen presenting cells carrying a CD11c driven mutation in the major cell-surface glycan sulfating enzyme N-deacetylase/N-sulfotransferase (Ndst1) are associated with augmented induction of anti-tumor CD8+ cytotoxic T cells relative to that of wildtype antigen presenting cells (APCs) [1, 2]. Here, ITGAX is linked to neoplasm.